Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-13

FDA Approved: HALOPERIDOL DECANOATE — Original Application (Caplin Steriles Limited)

View source ↗

Summary

The FDA approved HALOPERIDOL DECANOATE as an original application for a generic long-acting injectable, used to treat schizophrenia. The submission was made by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

ORIG AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)